Breuer K et al. |
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. |
2005 |
Am J Clin Dermatol |
pmid:15799678
|
Kalavala M and Dohil MA |
Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence. |
2011 |
Am J Clin Dermatol |
pmid:21067248
|
Patel TS et al. |
Cancer concerns with topical immunomodulators in atopic dermatitis: overview of data and recommendations to clinicians. |
2007 |
Am J Clin Dermatol |
pmid:17645374
|
Ingram JR et al. |
Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. |
2009 |
Am J Clin Dermatol |
pmid:19489656
|
Ramirez R et al. |
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. |
2017 |
Am J Case Rep |
pmid:28465499
|
Kawamura H et al. |
Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases. |
2017 |
Am J Case Rep |
pmid:28411286
|
Udomkarnjananun S et al. |
An Unusual Manifestation of Calcineurin Inhibitor-Induced Pain Syndrome in Kidney Transplantation: A Case Report and Literature Review. |
2018 |
Am J Case Rep |
pmid:29654227
|
Baran DA et al. |
Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment. |
2004 |
Am J Cardiovasc Drugs |
pmid:14967063
|
Mcauliffe EP |
Is tacrolimus the best therapy for atopic dermatitis? |
2003 |
Am Fam Physician |
pmid:12751651
|
Lane JE and Johnson J |
Persistent penile patch. |
2008 |
Am Fam Physician |
pmid:19007056
|
Russell JJ |
Topical tacrolimus: a new therapy for atopic dermatitis. |
2002 |
Am Fam Physician |
pmid:12469964
|
Berke R et al. |
Atopic dermatitis: an overview. |
2012 |
Am Fam Physician |
pmid:22962911
|
Hitzeman N and Kinnevey C |
Topical Tacrolimus for Eczema. |
2016 |
Am Fam Physician |
pmid:27929217
|
Wilhelmi E et al. |
Organotypic brain-slice cultures from adult rats: approaches for a prolonged culture time. |
2002 May-Jun |
Altern Lab Anim |
pmid:12106005
|
Kay AB |
Immunosuppressive agents in chronic severe asthma. |
1994 May-Jun |
Allergy Proc |
pmid:7523242
|
Leonardi S et al. |
Efficacy and safety of tacrolimus ointment 0.03% treatment in a 1-month-old "red baby": a case report. |
2006 Nov-Dec |
Allergy Asthma Proc |
pmid:17176789
|
Pacor ML et al. |
Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. |
2006 Nov-Dec |
Allergy Asthma Proc |
pmid:17176790
|
Rico MJ and Lawrence I |
Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects. |
2002 May-Jun |
Allergy Asthma Proc |
pmid:12125507
|
Szema AM |
Angioedema in a child with a liver transplant, intussusception, and normal c4 levels. |
2010 Jul-Aug |
Allergy Asthma Proc |
pmid:20615276
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18445188
|
Jensen JM et al. |
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. |
2012 |
Allergy |
pmid:22142306
|
Bieber T et al. |
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. |
2007 |
Allergy |
pmid:17298428
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18592619
|
Bergstrand H and Lundquist B |
Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner. |
1992 |
Allergy |
pmid:1280915
|
Kaufmann R et al. |
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. |
2006 |
Allergy |
pmid:16436149
|
Oldhoff JM et al. |
Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%. |
2006 |
Allergy |
pmid:16629794
|
Simon D et al. |
Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. |
2005 |
Allergy |
pmid:15932386
|
Inoue Y et al. |
Food allergy after cord blood stem cell transplantation with tacrolimus therapy in two patients who developed veno-occlusive disease. |
2012 |
Allergol Int |
pmid:22722810
|
Tsuji T et al. |
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. |
2016 |
Allergol Int |
pmid:26666476
|
Miyachi Y et al. |
Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study. |
2007 |
Allergol Int |
pmid:17582208
|
Ebihara N et al. |
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. |
2012 |
Allergol Int |
pmid:22361511
|
Yamamoto M et al. |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. |
2007 |
Allergol Int |
pmid:17460441
|
Ortiz de Frutos FJ |
[New horizons in the treatment of atopic dermatitis]. |
|
Allergol Immunopathol (Madr) |
pmid:11988144
|
Mori F et al. |
Increase of natural killer cells in children with liver transplantation-acquired food allergy. |
|
Allergol Immunopathol (Madr) |
pmid:29456038
|
Regueiro-GarcÃa A et al. |
Haploidentical stem cell transplantation in a boy with chronic granulomatous disease. |
|
Allergol Immunopathol (Madr) |
pmid:29373243
|
Schmidt KJ et al. |
Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - authors' reply. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336691
|
Yamamoto T et al. |
Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26762838
|
Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Travis S |
Review article: saving the colon in severe colitis - the case for medical therapy. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16961749
|
Romano C et al. |
Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20148798
|
McSharry K et al. |
Systematic review: the role of tacrolimus in the management of Crohn's disease. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21999607
|
Beckebaum S et al. |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. |
2009 |
Aliment. Pharmacol. Ther. |
pmid:19624550
|
Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Trotter JF et al. |
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15963078
|
Yamamoto T et al. |
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137731
|
Laharie D and Poullenot F |
Letter: which patient profile for tacrolimus in ulcerative colitis? |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137730
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|